Teva Pharm. United States, Inc. v. Superior Court of Cal.
135 S. Ct. 1152, 190 L. Ed. 2d 911, 83 U.S.L.W. 3608, 2015 U.S. LEXIS 687
CourtSupreme Court of the United States
DecidedJanuary 20, 2015
DocketNo. 13–956.
StatusPublished
Cited by2 cases
This text of 135 S. Ct. 1152 (Teva Pharm. United States, Inc. v. Superior Court of Cal.) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Teva Pharm. United States, Inc. v. Superior Court of Cal., 135 S. Ct. 1152, 190 L. Ed. 2d 911, 83 U.S.L.W. 3608, 2015 U.S. LEXIS 687 (U.S. 2015).
Opinion
Opinion *1153Petition for writ of certiorari to the Court of Appeal of California, Fourth Appellate District, Division Three, denied.
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Wagner v. Teva Pharmaceuticals USA, Inc.
840 F.3d 355 (Seventh Circuit, 2016)
Kathleen Wagner v. Teva Pharmaceuticals USA, Inc.
Seventh Circuit, 2016
Cite This Page — Counsel Stack
Bluebook (online)
135 S. Ct. 1152, 190 L. Ed. 2d 911, 83 U.S.L.W. 3608, 2015 U.S. LEXIS 687, Counsel Stack Legal Research, https://law.counselstack.com/opinion/teva-pharm-united-states-inc-v-superior-court-of-cal-scotus-2015.